Substituted biaryl quinolin-4-ylamine analogues
US7935702B2 · kind B2 · utility
3Cited by
10References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 12, 2005 |
| Grant date | May 3, 2011 |
| Priority date | — |
| Expiry date | Sep 10, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Substituted biaryl quinolin-4-ylamine analogues of Formula I are provided.Such compounds are ligands that may be used to modulate specific receptor activity in vivo or in vitro, and are particularly useful in the treatment of conditions associated with pathological receptor activation in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for using such compounds to treat such disorders are provided, as are methods for using such ligands for receptor localization studies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.